Cargando…
Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention
Age-related increases in prevalent dementia over the next 30–40 years risk collapsing medical resources or radically altering the way we treat patients. Better prevention of dementia therefore needs to be one of our highest medical priorities. We propose a perspective on the pathological basis of de...
Autores principales: | Valenzuela, M, Esler, M, Ritchie, K, Brodaty, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337069/ https://www.ncbi.nlm.nih.gov/pubmed/22832907 http://dx.doi.org/10.1038/tp.2012.28 |
Ejemplares similares
-
Comparison of Antihypertensive Drug Classes for Dementia Prevention
por: Walker, Venexia M., et al.
Publicado: (2020) -
Polyphenols for the prevention and treatment of dementia diseases
por: Hügel, Helmut M., et al.
Publicado: (2015) -
Antibiotics: Combatting Tolerance To Stop Resistance
por: Windels, Etthel M., et al.
Publicado: (2019) -
Do Patient Concerns About Antihypertensive Use For Dementia Prevention Vary By Current Use Of Antihypertensive?
por: Lee, Woojung, et al.
Publicado: (2019) -
COVID‐19, physical (in‐)activity, and dementia prevention
por: Müller, Patrick, et al.
Publicado: (2020)